AbCellera Biologics Inc. (ABCL) — Business segments and KPIs
Revenue by business segment and geography for AbCellera Biologics Inc., with year-over-year trends.
FY 2025
| Segment | Revenue | % of total |
|---|---|---|
| Revenue by product | ||
| License | 46.92M | 62.5% |
| Research Fees | 27.21M | 36.2% |
| Milestone Payments | 1.00M | 1.3% |
| Revenue by region | ||
| CANADA | 64.00M | 85.2% |
| UNITED STATES | 11.10M | 14.8% |